The origin and functions of natural killer cells

Clinical Immunology

Volumn 95, Issue 1 II, 2000, Pages

  Lanier, Lewis L ^a,b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CYTOKINE; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; BINDING AFFINITY; CELLULAR IMMUNITY; CONFERENCE PAPER; DISEASE PREDISPOSITION; HLA SYSTEM; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; T LYMPHOCYTE SUBPOPULATION;

EID: 0034115748     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4816     Document Type: Conference Paper

References (95)

1. Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., and Salazar-Mather, T. P., Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189-220, 1999.
2. Unanue, E. R., Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance. Curr. Opin. Immunol. 9, 35-43, 1997.
3. Scott, P., and Trinchieri, G., The role of natural killer cells in host-parasite interactions. Curr. Opin. Immunol. 7, 34-40, 1995.
4. Spits, H., Lanier, L. L., and Phillips, J. H., Development of human T and natural killer cells. Blood 85, 2654-2670, 1995.
5. Sanchez, M. J., Spits, H., Lanier, L. L., and Phillips, J. H., Human natural killer cells committed thymocytes and their relation to the T cell lineage. J. Exp. Med. 178, 1857-1866, 1993.
6. Sanchez, M. J., Muench, M. O., Roncarolo, M. G., Lanier, L. L., and Phillips, J. H., Identification of a common T/natural killer cell progenitor in human fetal thymus. J. Exp. Med. 180, 569-576, 1994.
7. Trinchieri, G., Biology of natural killer cells. Adv. Immunol. 47, 187-376, 1989.
8. Lanier, L. L., Le, A. M., Civin, C. I., Loken, M. R., and Phillips, J. H., The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol. 136, 4480-4486, 1986.
9. Perussia, B., Starr, S., Abraham, S., Fanning, V., and Trinchieri, G., Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J. Immunol. 130, 2133-2141, 1983.
10. Lanier, L. L., Le, A. M., Phillips, J. H., Warner, N. L., and Babcock, G. F., Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J. Immunol. 131, 1789-1796, 1983.
11. Peritt, D., Robertson, S., Gri, G., Showe, L., Aste-Amezaga, M., and Trinchieri, G., Differentiation of human NK cells into NK1 and NK2 subsets. J. Immunol. 161, 5821-5824, 1998.
12. Cuturi, M. C., Murphy, M., Costa-Giomi, M. P., Weinmann, R., Perussia, B., and Trinchieri, G., Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J. Exp. Med. 165, 1581-1594, 1987.
13. Cuturi, M. C., Anegon, I., Sherman, F., Loudon, R., Clark, S. C., Perussia, B., and Trinchieri, G., Production of hematopoietic colony-stimulating factors by human natural killer cells. J. Exp. Med. 169, 569-583, 1989.
14. Fehniger, T. A., Shah, M. H., Turner, M. J., Van Deusen, J. B., Whitman, S. P., Cooper, M. A., Suzuki, K., Wechser, M., Goodsaid, F., and Caligiuri, M. A., Differential cytokine and chemokine gene expression by human NK Cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response. J. Immunol. 162, 4511-4520, 1999.
15. Bluman, E. M., Bartynski, K. J., Avalos, B. R., and Caligiuri, M. A., Human natural killer cells produce abundant macrophage inflammatory protein-1α in response to monocyte-derived cytokines. J. Clin. Invest. 97, 2722-2727, 1996.
16. Fehniger, T. A., Herbein, G., Yu, H., Para, M. I., Bernstein, Z. P., O'Brien, W. A., and Caligiuri, M. A., Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. J. Immunol. 161, 6433-6438, 1998.
17. Warren, H. S., Kinnear, B. F., Phillips, J. H., and Lanier, L. L., Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10 and IL-12. J. Immunol. 154, 5144-5152, 1995.
18. Biron, C. A., Byron, K. S., and Sullivan, J. L., Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320, 1731-1735, 1989.
19. Ballas, Z. K., Turner, J. M., Turner, D. A., Goetzman, E. A., and Kemp, J. D., A patient with simultaneous absence of 'classical' natural killer cells (CD3-, CD16- and NKH1+) and expansion of CD3+,CD4-,CD8-,NKH1+ subset. J. Allergy Clin. Immunol. 85, 453-459, 1990.
20. Joncas, J., Monczak, Y., Ghibu, F., Alfieri, C., Bonin, A., Ahronheim, G., and Rivard, G., Brief report: Killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection. J. Med. Virol. 28, 110-117, 1989.
21. Bukowski, J. F., Warner, J. F., Dennert, G., and Welsh, R. M., Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J. Exp. Med. 161, 40-52, 1985.
22. Welsh, R. M., Burbaker, J. O., Vargas-Cortes, M., and O'Donnell, C. L., Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency: The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell functions. J. Exp. Med. 173, 1053-1063, 1991.
23. Scalzo, A. A., Fitzgerald, N. A., Simmons, A., La Vista, A. B., and Shellam, G. R., Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 171, 1469-1483, 1990.
24. Scalzo, A. A., Fitzgerald, N. A., Wallace, C. R., Gibbons, A. E., Smart, Y. C., Burton, R. C., and Shellam, G. R., The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J. Immunol. 149, 581-589, 1992.
25. Scalzo, A. A., Shellam, G. R., Fitzgerald, N. A., Wallace, C. R., Lyons, P. A., and Yokoyama, W. M., The Cmv-1 resistance gene is closely linked to loci residing in the NKC region on mouse chromosome 6. FASEB J. 6, A2053, 1992.
26. Forbes, C. A., Brown, M. G., Cho, R., Shellam, G. R., Yokoyama, W. M., and Scalzo, A. A., The Cmv1 host resistance locus is closely linked to the Ly49 multigene family within the natural killer cell complex on mouse chromosome 6. Genomics 41, 406-413, 1997.
27. Bancroft, G. J., Schreiber, R. D., Bosma, G. C., Bosma, M. J., and Unanue, E. R., A T cell-independent mechanism of macrophage activation by interferon-γ. J. Immunol. 139, 1104-1107, 1987.
28. Wherry, J. C., Schreiber, R. D., and Unanue, E. R., Regulation of gamma interferon production by natural killer cells in scid mice: Role of tumor necrosis factor and bacterial stimuli. Infect. Immun. 59, 1709-1715, 1991.
29. Doolan, D. L., and Hoffman, S. L., IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the plasmodium yoelii model. J. Immunol. 163, 884-892, 1999.
30. Sher, A., Oswald, I. P., Hieny, S., and Gazzinelli, R. T., Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α. J. Immunol. 150, 3982-3989, 1993.
31. Denkers, E. Y., Gazzinelli, R. T., Martin, D., and Sher, A., Emergence of NK1.1+ cells as effectors of IFN-g dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J. Exp. Med. 178, 1465-1472, 1993.
32. Laskay, T., Rollinghoff, M., and Solbach, W., Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur. J. Immunol. 23, 2237-2241, 1993.
33. Ljunggren, H.-G., and Karre, K., Host resistance directed selectively against H-2-deficient lymphoma variants: Analysis of the mechanism. J. Exp. Med. 162, 1745-1759, 1985.
34. Piontek, G. E., Taniguchi, K., Ljunggren, H.-G., Gronberg, A., Kiessling, R., Klein, G., and Karre, K., YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. J. Immunol. 135, 4281-4288, 1985.
35. Karre, K., Ljunggren, H. G., Piontek, G., and Kiessling, R., Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319, 675-678, 1986.
36. Lanier, L. L., NK cell receptors. Annu. Rev. Immunol. 16, 359-393, 1998.
37. Long, E. O., Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17, 875-904, 1999.
38. Lanier, L. L., Follow the leader: NK cell receptors for classical and non-classical MHC class I. Cell 92, 705-707, 1998.
39. + IL-2-activated natural killer cells. Nature 358, 66-70, 1992.
40. Yokoyama, W. M., Jacobs, L. B., Kanagawa, O., Shevach, E. M., and Cohen, D. I., A murine T lymphocyte antigen belongs to a supergene family of type II integral membrane proteins. J. Immunol. 143, 1379-1386, 1989.
41. Smith, H. R. C., Karlhofer, F. M., and Yokoyama, W. M., Ly-49 multigene family expressed by IL-2-activated NK cells. J. Immunol. 153, 1068-1079, 1994.
42. Hanke, T., Takizawa, H., McMahon, C. W., Busch, D. H., Pamer, E. G., Miller, J. D., Altman, J. D., Liu, Y., Cado, D., Lemonnier, F. A., Bjorkman, P. J., and Raulet, D. H., Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11, 67-77, 1999.
43. Brennan, J., Mager, D., Jefferies, W., and Takei, F., Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J. Exp. Med. 180, 2287-2295, 1994.
44. Daniels, B., Karlhofer, F. M., Seaman, W. E., and Yokoyama, W. M., A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J. Exp. Med. 180, 687-692, 1994.
45. Kane, K. P., Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J. Exp. Med. 179, 1011-1015, 1994.
46. Brennan, J., Mahon, G., Mager, D. L., Jefferies, W. A., and Takei, F., Recognition of class I major histocompatibility complex molecules by Ly-49: Specificities and domain interactions. J. Exp. Med. 183, 1553-1559, 1996.
47. Nakamura, M. C., Niemi, E. C., Fisher, M. J., Shultz, L. D., Seaman, W. E., and Ryan, J. C., Mouse Ly49A interrupts early signaling events in NK cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J. Exp. Med. 185, 673-684, 1997.
48. Olcese, L., Lang, P., Vely, F., Cambiaggi, A., Marguet, D., Blery, M., Hippen, K. L., Biassoni, R., Moretta, A., Moretta, L., Cambier, J. C., and Vivier, E., Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immunol. 156, 4531-4534, 1996.
49. Westgaard, I. H., Berg, S. F., Orstavik, S., Fossum, S., and Dissen, E., Identification of a human member of the Ly-49 multigene family. Eur. J. Immunol. 28, 1839-1846, 1998.
50. Barten, R., and Trowsdale, J., The human Ly-49L gene. Immunogenetics 49, 731-734, 1999.
51. Wagtmann, N., Rajagopalan, S., Winter, C. C., Peruzzi, M., and Long, E. O., Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3, 801-809, 1995.
52. Fan, Q. R., Garboczi, D. N., Winter, C. C., Wagtmann, N., Long, E. O., and Wiley, D. C., Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc. Natl. Acad. Sci. USA 93, 7178-7183, 1996.
53. Rojo, S., Wagtmann, N., and Long, E. O., Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: Requirement for all three p70 immunoglobulin domains. Eur. J. Immunol. 27, 568-571, 1997.
54. Dohring, C., and Colonna, M., Human natural killer cell inhibitory receptors bind to HLA class I molecules. Eur. J. Immunol. 26, 365-369, 1996.
55. Campbell, K. S., Dessing, M., Lopez-Botet, M., Cella, M., and Colonna, M., Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J. Exp. Med. 184, 93-100, 1996.
56. Burshtyn, D. N., Scharenberg, A. M., Wagtmann, N., Rajagopalan, S., Berrada, K., Yi, T., Kinet, J.-P., and Long, E. O., Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4, 77-85, 1996.
57. Fry, A., Lanier, L. L., and Weiss, A., Phosphotyrosines in the KIR motif of NKB1 are required for negative signaling and for association with PTP1C. J. Exp. Med. 184, 295-300, 1996.
58. Lazetic, S., Chang, C., Houchins, J. P., Lanier, L. L., and Phillips, J. H., Human NK cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 157, 4741-4745, 1996.
59. Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Soderstrom, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., Lanier, L. L., and McMichael, A. J., HLA-E binds to natural killer cell receptors CD94/NKG2A, B, and C. Nature 391, 795-798, 1998.
60. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., Lopez-Botet, M., and Geraghty, D. E., HLA-E is a major ligand for the NK inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95, 5199-5204, 1998.
61. Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E., and Brooks, A. G., Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187, 813-818, 1998.
62. Vance, R. E., Kraft, J. R., Altman, J. D., Jensen, P. E., and Raulet, D. H., Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188, 1841-1848, 1998.
63. Aldrich, C. J., DeCloux, A., Woods, A. S., Cotter, R. J., Soloski, M. J., and Forman, J., Identification of a TAP-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 79, 649-658, 1994.
64. Braud, V., Jones, E. Y., and McMichael, A., The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 27, 1164-1169, 1997.
65. Lee, N., Goodlett, D. R., Ishitani, A., Marquardt, H., and Geraghty, D. E., HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160, 4951-4960, 1998.
66. Samaridis, J., and Colonna, M., Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways. Eur. J. Immunol. 27, 660-665, 1997.
67. Cosman, D., Fanger, N., Borges, L., Kibin, M., Chin, W., Peterson, L., and Hsu, M.-L., A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7, 273-282, 1997.
68. Navarro, F., Llano, M., Bellon, T., Colonna, M., Geraghty, D. E., and Lopez-Botet, M., The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 29, 277-283, 1999.
69. Colonna, M., Samaridis, J., Cella, M., Angman, L., Allen, R. L., O'Callaghan, C. A., Dunbar, R., Ogg, G. S., Cerundolo, V., and Rollick, A., Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160, 3096-3100, 1998.
70. Colonna, M., Navarro, F., Bellon, T., Llano, M., Garcia, P., Samaridis, J., Angman, L., Cella, M., and Lopez-Botet, M., A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186, 1809-1818, 1997.
71. Fanger, N. A., Cosman, D., Peterson, L., Braddy, S. C., Maliszewski, C. R., and Borges, L., The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur. J. Immunol. 28, 3423-3434, 1998.
72. Vitale, M., Castriconi, R., Parolini, S., Pende, D., Hsu, M.-L., Moretta, L., Cosman, D., and Moretta, A., The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: Analysis of LIR-1 + NK cell clones. Int. Immunol. 11, 29-36, 1999.
73. Valiante, N. M., Uhrberg, M., Shilling, H. G., Lienert-Weidenbach, K., Arnett, K. L., D'Andrea, A., Phillips, J. H., Lanier, L. L., and Parham, P., Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7, 739-751, 1997.
74. Gumperz, J. E., Valiante, N. M., Parham, P., Lanier, L. L., and Tyan, D., Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different HLA types appear genetically regulated, but not linked to MHC haplotype. J. Exp. Med. 183, 1817-1827, 1996.
75. Siliciano, R. F., Pratt, J. C., Schmidt, R. E., Ritz, J., and Reinherz, E. L., Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature 317, 428-430, 1985.
76. Schmidt, R. E., Hercend, T., Fox, D. A., Bensussan, A., Bartley, G., Daley, J. F., Schlossman, S. F., Reinherz, E. L., and Ritz, J., The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones. J. Immunol. 135, 672-678, 1985.
77. Lanier, L. L., Corliss, B., and Phillips, J. H., Arousal and inhibition of human NK cells. Immunol. Rev. 155, 145-154, 1997.
78. Lanier, L. L., Ruitenberg, J. J., and Phillips, J. H., Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J. Immunol. 141, 3478-3485, 1988.
79. Shibuya, A., Campbell, D., Hannum, C., Yssel, H., Franz-Bacon, K., McClanahan, T., Kitamura, T., Nicholl, J., Sutherland, G. R., Lanier, L. L., and Phillips, J. H., DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4, 573-581, 1996.
80. Galandrini, R., De Maria, R., Piccoli, M., Frati, L., and Santoni, A., CD44 triggering enhances human NK cell cytotoxic functions. J. Immunol. 153, 4399-4407, 1994.
81. Moretta, A., Poggi, A., Pende, D., Tripodi, G., Orengo, A. M., Pella, N., Augugliaro, R., Bottino, C., Ciccone, E., and Moretta, L., CD69-mediated pathway of lymphocyte activation: Anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor α/β. J. Exp. Med. 174, 1393-1398, 1991.
82. Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., and Moretta, A., NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187, 2065-2072, 1998.
83. Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., and Moretta, A., p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J. Exp. Med. 186, 1129-1136, 1997.
84. Tangye, S. G., Lazetic, S., Woollatt, E., Sutherland, G. R., Lanier, L. L., and Phillips, J. H., Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol. 162, 6981-6985, 1999.
85. Nakajima, H., Cella, M., Langen, H., Friedlein, A., and Colonna, M., Activating interactions in human NK cell recognition: The role of 2B4-CD48. Eur. J. Immunol. 29, 1676-1683, 1999.
86. Moretta, L., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C., and Moretta, L., Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182, 875-884, 1995.
87. Biassoni, R., Cantoni, C., Falco, M., Verdiani, S., Bottino, C., Vitale, M., Conte, R., Poggi, A., Moretta, A., and Moretta, L., The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183, 645-650, 1996.
88. Mason, L. H., Anderson, S. K., Yokoyama, W. M., Smith, H. R. C., Winkler-Pickett, R., and Ortaldo, J. R., The Ly-49D receptor activates murine natural killer cells. J. Exp. Med. 184, 2119-2128, 1996.
89. Nakamura, M. C., Linnemeyer, P. A., Niemi, E. C., Mason, L. H., Ortaldo, J. R., Ryan, J. C., and Seaman, W. E., Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity. J. Exp. Med. 189, 493-500, 1999.
90. Houchins, J. P., Lanier, L. L., Niemi, E., Phillips, J. H., and Ryan, J. C., Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 158, 3603-3609, 1997.
91. Cantoni, C., Biassoni, R., Pende, D., Sivori, S., Accame, L., Pareti, L., Semenzato, G., Moretta, L., Moretta, A., and Bottino, C., The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur. J. Immunol. 28, 327-338, 1998.
92. Lanier, L. L., Corliss, B. C., Wu, J., Leong, C., and Phillips, J. H., Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391, 703-707, 1998.
93. Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H., and Lanier, L. L., Ly49D and Ly49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161, 7-10, 1998.
94. Lanier, L. L., Corliss, B., Wu, J., and Phillips, J. H., Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8, 693-701, 1998.
95. McVicar, D. W., Taylor, L. S., Gosselin, P., Willette-Brown, J., Mikhael, A. I., Geahlen, R. L., Nakamura, M. C., Linnemeyer, P., Seaman, W. E., Anderson, S. K., Ortaldo, J. R., and Mason, L. H., DAP12-mediated signal transduction in natural killer cells: A dominant role for the syk protein-tyrosine kinase. J. Biol. Chem. 273, 32934-32942, 1998.